150 results match your criteria Spur Cell Anemia


Binge drinking alongside alcoholic chronic abuse.

Morphologie 2022 May 20. Epub 2022 May 20.

Service d'hématologie biologique, centre hospitalier universitaire, Nancy, France.

Here is reported the case of an adult patient with ethylic cirrhosis associated with spur cell anemia. Moreover, acute vacuolation of leukocytes was observed in relationship with recent binge drinking. Read More

View Article and Full-Text PDF

Spur-Cell Hemolytic Anemia.

N Engl J Med 2022 Jan;386(4):e6

Vanderbilt University Medical Center, Nashville, TN

View Article and Full-Text PDF
January 2022

Red blood cell abnormalities occur in dogs with congenital ventricular outflow tract obstruction.

Am J Vet Res 2021 Dec 21;83(3):198-204. Epub 2021 Dec 21.

Unité de Biochimie et Biologie Clinique/Laboratoire BioPôle, École Nationale Vétérinaire d'Alfort, Université Paris-Est, Maisons-Alfort, France.

Objective: To document RBC abnormalities in dogs with congenital ventricular outflow tract obstruction.

Animals: 62 dogs with pulmonic stenosis (PS) or aortic stenosis (AS) and 20 control dogs were recruited.

Procedures: The proportions of RBCs that were schistocytes, acanthocytes, and keratocytes were assessed. Read More

View Article and Full-Text PDF
December 2021

Profile of Medicaid enrollees with sickle cell disease: A high need, high cost population.

PLoS One 2021 27;16(10):e0257796. Epub 2021 Oct 27.

Manatt Health Strategies, Washington, DC, United States of America.

Sickle cell disease is a progressively debilitating genetic condition that affects red blood cells and can result in a variety of serious medical complications, reduced life expectancy, and diminished quality of life. Medicaid nationwide covered 66 percent of sickle cell disease hospitalizations in 2004 and 58 percent of emergency department visits for the disease between 1999 and 2007. Using Medicaid data from four states with large populations that account for more than one-third of Medicaid program enrollment, we examined the characteristics of those with sickle cell disease. Read More

View Article and Full-Text PDF
November 2021

Impact of a grant program to spur advances in sickle cell disease research.

Blood Adv 2021 10;5(19):3855-3861

Consultant, New York, NY.

More than 20 years ago, clinical trials and federal grant support for sickle cell disease (SCD) research were not on par with support for other genetic diseases. Faced with the opportunity to spur research and advance treatments for SCD, and at the recommendation of advisors, the Doris Duke Charitable Foundation (DDCF) offered an SCD research funding opportunity starting in 2009 through its Innovations in Clinical Research Awards (ICRA) program. Twenty-eight new grants of $450 000 for direct costs over 3 years and 7 renewals were awarded, for a total investment of $17 million. Read More

View Article and Full-Text PDF
October 2021

Predictors of mortality and outcomes of liver transplant in spur cell hemolytic anemia.

Am J Hematol 2021 12 7;96(12):1611-1620. Epub 2021 Oct 7.

Harvard Medical School, Boston, Massachusetts, USA.

Spur cell hemolytic anemia (SCHA) is a rare, acquired, nonimmune hemolytic anemia of decompensated cirrhosis. Data describing prognostic impact, outcomes of liver transplant, and clinical hematologic characteristics of SCHA are absent or limited. We performed a multicenter, 24-year observational cohort study of patients with SCHA, retrospectively analyzing hepatic and hematologic parameters, independent predictors of mortality, and long-term outcomes of liver transplant. Read More

View Article and Full-Text PDF
December 2021

The Diagnosis Is in the Smear: A Case and Review of Spur Cell Anemia in Cirrhosis.

Case Rep Hematol 2021 26;2021:8883335. Epub 2021 Mar 26.

Department of Medicine, Division of Hematology, University of Miami, Miami, FL, USA.

The etiology of anemia in liver cirrhosis is multifactorial; one less recognized cause is hemolytic anemia due to spur cells, known as spur cell anemia. We present the case of a 57-year-old woman with alcoholic cirrhosis who presented with symptomatic macrocytic anemia with a hemoglobin level of 7.4 g/dL and signs of decompensated liver disease. Read More

View Article and Full-Text PDF

Movement Disorders and Hematologic Diseases.

Mov Disord Clin Pract 2021 Feb 29;8(2):193-207. Epub 2020 Dec 29.

Department of Neurological Sciences Rush University Medical Center Chicago Illinois USA.

Background: Movement disorders can be associated with or caused by hematological abnormalities. The objective of this review is to highlight features that will aid in the clinician's recognition and treatment of these disorders.

Methods: MESH terms relevant to movement disorders and hematologic diseases were searched to identify conditions included in this narrative, educational review. Read More

View Article and Full-Text PDF
February 2021

Severe Candida glabrata pancolitis and fatal Aspergillus fumigatus pulmonary infection in the setting of bone marrow aplasia after CD19-directed CAR T-cell therapy - a case report.

BMC Infect Dis 2021 Jan 28;21(1):121. Epub 2021 Jan 28.

Department of Hematology and Oncology, University Hospital, LMU Munich, Munich, Germany.

Background: Prolonged myelosuppression following CD19-directed CAR T-cell transfusion represents an important, yet underreported, adverse event. The resulting neutropenia and multifactorial immunosuppression can facilitate severe infectious complications.

Case Presentation: We describe the clinical course of a 59-year-old patient with relapsed/refractory DLBCL who received Axicabtagene-Ciloleucel (Axi-cel). Read More

View Article and Full-Text PDF
January 2021

Spur-cell anemia.

Cleve Clin J Med 2020 11 2;87(11):649-650. Epub 2020 Nov 2.

James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY.

View Article and Full-Text PDF
November 2020

Spur Cells Causing Severe and Transfusion-Refractory Anemia in Patients With Acute-on-Chronic Liver Failure.

Cureus 2020 Sep 21;12(9):e10568. Epub 2020 Sep 21.

Gastroenterology, All India Institute of Medical Sciences, Patna, IND.

Acute-on-chronic liver failure (ACLF) is characterized by acute decompensation of chronic liver disease associated with organ failures. Anemia of diverse etiology is common in patients with ACLF. Spur cell anemia (SCA) is a form of acquired hemolytic anemia that occurs rarely in such patients due to dysregulated lipids metabolism. Read More

View Article and Full-Text PDF
September 2020

Erythrocyte viscoelastic recovery after liver transplantation in a cirrhotic patient affected by spur cell anaemia.

J Microsc 2020 12 17;280(3):287-296. Epub 2020 Sep 17.

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.

In physiological conditions, red blood cells (RBCs) are capable of dramatic deformations when passing through the microvasculature. This extreme deformability is closely related to the RBC biconcave shape, to the fluidic nature of the haemoglobin and the cell membrane structure, primarily consisting of a phospholipid bilayer with an underlying two-dimensional spectrin network. In many pathological and inflammatory conditions, the shape and the extreme deformability of erythrocytes appear to be significantly altered. Read More

View Article and Full-Text PDF
December 2020

Spur cell anemia related to alcoholic liver cirrhosis managed without liver transplantation: a case report and literature review.

Clin J Gastroenterol 2020 Oct 29;13(5):882-890. Epub 2020 May 29.

Department of Gastroenterology, Gifu University Graduate School of Medicine, Gifu, Japan.

Spur cell anemia is an acquired hemolytic anemia associated with liver cirrhosis and is characterized by the presence of increased large red blood cells, which are covered with spike-like projections that vary in width, length, and distribution. A 26-year-old man was referred to our hospital presenting with jaundice, lower limb edema, and dyspnea. The patient was subsequently diagnosed with spur cell anemia related to alcoholic liver cirrhosis. Read More

View Article and Full-Text PDF
October 2020

Single red blood cell analysis reveals elevated hemoglobin in poikilocytes.

J Biomed Opt 2020 01;25(1):1-13

City Univ. of Hong Kong, China.

Abnormally shaped red blood cells (RBCs), called poikilocytes, can cause anemia. At present, the biochemical abnormalities in poikilocytes are not well understood. Normal RBCs and poikilocytes were analyzed using whole-blood and single-cell methods. Read More

View Article and Full-Text PDF
January 2020

[Diagnosis of anemia associated with alcoholic cirrhosis].

Rev Med Liege 2019 Oct;74(10):527-534

Service de Gastro-Entérologie et Hépatologie, CHU Liège, Belgique.

We report here the case of a 62-year-old patient with Child-Pugh stage C ethylic cirrhosis associated with severe macrocytic anaemia, refractory to iterative transfusions and withdrawal. After a haemorrhagic, deficiency-related, or sideroblastic etiology was ruled out, haemolytic anaemia was suspected. A blood smear allowed diagnosis of haemolytic anaemia with acanthocytes. Read More

View Article and Full-Text PDF
October 2019

Autosplenectomy in a Patient with Paroxysmal Nocturnal Hemoglobinuria (PNH).

Case Rep Hematol 2019 12;2019:3146965. Epub 2019 Feb 12.

Houston Methodist Hospital, Department of Medicine, 6550 Fannin St, Houston, TX 77030, USA.

Autosplenectomy (AS) is a known complication of diseases such as sickle cell anemia, celiac disease, and inflammatory bowel disease. We report the first known case of AS due to paroxysmal nocturnal hemoglobinuria (PNH). A 24-year-old Caucasian male had evidence of hemolytic anemia at the age of 14 and was diagnosed with PNH at the age of 16. Read More

View Article and Full-Text PDF
February 2019

Spur-Cell Anemia.

N Engl J Med 2018 Aug;379(8):774

Oregon Health and Science University, Portland, OR

View Article and Full-Text PDF

Plasmapheresis for Spur Cell Anemia in a Patient with Alcoholic Liver Cirrhosis.

Case Rep Hematol 2018 21;2018:9513946. Epub 2018 Jun 21.

Department of Laboratory Medicine, Uji-Tokushukai Medical Center, Uji 611-0042, Japan.

Background: Spur cell anemia (SCA) is a cause of hemolytic anemia in patients with alcoholic liver cirrhosis. Because dyslipidemia is related to the development of spur cells, SCA was previously treated with plasmapheresis.

Case Report: A 52-year-old Japanese man with SCA associated with alcoholic liver cirrhosis (Child-Pugh C) underwent two rounds of plasmapheresis. Read More

View Article and Full-Text PDF

High-dose steroids as a therapeutic option in the management of spur cell haemolytic anaemia.

BMJ Case Rep 2018 Jan 31;2018. Epub 2018 Jan 31.

Medical Oncology/Medicine, Captain James A. Lovell Federal Health Care Center, North Chicago, Illinois, USA.

Spur cell haemolytic anaemia (SCA) is a form of anaemia that can be seen in patients with severely impaired liver function or advanced cirrhosis. It is associated with high mortality. The treatment options for SCA secondary to cirrhosis are limited. Read More

View Article and Full-Text PDF
January 2018

Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance.

Dig Dis Sci 2018 Jan 25;63(1):16-26. Epub 2017 Nov 25.

Department of Clinical and Experimental Medicine, Garibaldi Hospital, University of Catania, Via Palermo, 636, 95122, Catania, Italy.

Progressive lipoprotein impairment occurs in liver cirrhosis and is associated with increased morbidity and mortality. The present review aims to summarize the current evidence regarding the prognostic value of lipoprotein abnormalities in liver cirrhosis and to address the need of a better prognostic stratification of patients, including lipoprotein profile assessment. Low levels of lipoproteins are usual in cirrhosis. Read More

View Article and Full-Text PDF
January 2018

Hepatocyte nuclear factor 1A deficiency causes hemolytic anemia in mice by altering erythrocyte sphingolipid homeostasis.

Blood 2017 12 6;130(25):2786-2798. Epub 2017 Nov 6.

Institute for Pathophysiology, West German Heart and Vascular Center and.

The hepatocyte nuclear factor (HNF) family regulates complex networks of metabolism and organ development. Human mutations in its prototypical member HNF1A cause maturity-onset diabetes of the young (MODY) type 3. In this study, we identified an important role for HNF1A in the preservation of erythrocyte membrane integrity, calcium homeostasis, and osmotic resistance through an as-yet unrecognized link of HNF1A to sphingolipid homeostasis. Read More

View Article and Full-Text PDF
December 2017

Next-generation sequencing unravels homozygous mutation in glucose-6-phosphate isomerase, GPIc.1040G>A (p.Arg347His) causing hemolysis in an Indian infant.

Clin Chim Acta 2017 May 20;468:81-84. Epub 2017 Feb 20.

Department of Hematology, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India. Electronic address:

Introduction: Inherited anemias diagnostic workup requires a step-wise algorithm. Causal genes implicated in congenital hemolytic anemia are numerous, making a gene-by-gene approach by Sanger sequencing time consuming, expensive and labour intensive. Targeted resequencing can be of great use in explaining these cases. Read More

View Article and Full-Text PDF

Unusual Anemias.

Med Clin North Am 2017 Mar 10;101(2):417-429. Epub 2016 Dec 10.

Division of Hematology/Medical Oncology, Department of Medicine, Oregon Health Sciences University, 3181 Southwest Sam Jackson Park Road, Portland, OR 97201-3098, USA; Division of Hematology/Medical Oncology, Department of Medicine, Knight Cancer Institute, Oregon Health and Science University, MC L586, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239, USA. Electronic address:

Many processes lead to anemia. This review covers anemias that are less commonly encountered in the United States. These anemias include hemoglobin defects like thalassemia, bone marrow failure syndromes like aplastic anemia and pure red cell aplasia, and hemolytic processes such as paroxysmal nocturnal hemoglobinuria. Read More

View Article and Full-Text PDF

Spur cell anemia in Wilson's disease: a rare presentation.

Int J Lab Hematol 2017 Jun 22;39(3):e64-e65. Epub 2016 Dec 22.

Department of Pediatrics, UCMS and GTB Hospital, New Delhi, India.

View Article and Full-Text PDF

An unusual cause of anemia in cirrhosis: spur cell anemia, a case report with review of literature.

Gastroenterol Hepatol Bed Bench 2016 ;9(4):335-339

Department of Clinical and Experimental Medicine, Garibaldi Hospital, University of Catania, Italy.

Chronic anemia is common in liver cirrhosis. In this setting, the pathogenesis of anemia is complex and multifactorial. Spur cell anemia is a serious disorder in cirrhotic patients and is associated with poor prognosis. Read More

View Article and Full-Text PDF
January 2016

Spur cell hemolytic anemia in liver failure.

Transfusion 2016 Apr;56(4):787-8

University of Washington, Harborview Medical Center, Seattle, Washington.

View Article and Full-Text PDF

Spur cell anemia in the setting of progressive liver allograft failure.

Am J Hematol 2016 Oct 22;91(10):1061. Epub 2016 Mar 22.

Division of Hematology, Mayo Clinic, Rochester, Minnesota.

View Article and Full-Text PDF
October 2016

[Spur cell anemia].

Rev Clin Esp (Barc) 2016 May 5;216(4):233. Epub 2015 Dec 5.

Servicio de Hematología, Hospital Universitario de Móstoles, Móstoles, Madrid, España.

View Article and Full-Text PDF